Rhythm Pharmaceuticals, Inc. RYTM Other Investments
Other Investments at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s other investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s other investments?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported other investments of $2.52M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s other investments changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s other investments decreased by 64.8% year-over-year, from $7.14M to $2.52M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s other investments?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s other investments has grown at a -27.4% compound annual growth rate (CAGR), from $11.82M to $3.29M.